Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Open-label, Randomised Controlled Clinical Trial to Investigate Early Efficacy of CYP-001 in Adults Admitted to Intensive Care With Respiratory Failure

NCT04537351 is registered in ClinicalTrials.gov with Cynata Therapeutics Limited as lead sponsor.

NCT NCT04537351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04537351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Open-label, Randomised Controlled Clinical Trial to Investigate Early Efficacy of CYP-001 in Adults Admitted to Intensive Care With Respiratory Failure
Lead sponsor
Cynata Therapeutics Limited
Phase
Phase 1
Overall status
Completed
Start date
August 24, 2020
Completion date
May 18, 2022
Enrollment
14 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid19